VANCOUVER, BC - June 3, 2026 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: "HBP", OTC PINK: "HBPCF", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near ...
Holders of Convertible Debentures have agreed to convert an aggregate principal amount of $1,335,500 into Common Shares, in accordance with the terms and conditions of the Convertible Debentures.
TORONTO--(BUSINESS WIRE)--Flow Beverage Corp. (TSX:FLOW; OTCQX:FLWBF) (“Flow” or the “Company”) today announced the closing of the first tranche of a non-brokered private placement offering (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results